Patient of the Month for August: Julie Durkee
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Julie Durkee shares her story.
LRG Receives COVID-19 Rapid Response Seed Grants from NORD
The National Organization for Rare Diseases (NORD) has awarded 19 seed grants to non-profit organizations that have been adversely affected by the COVID-19 pandemic. The pandemic has created a financial crisis for non-profits due to the cancellation of large events, particularly fundraisers upon which these organizations depend.
Caregiver of the Month for July: Amelia Yeo
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Amelia Yeo shares her story.
Life Raft Group Collaborates on White Paper Published by Cancer Leaders
The Life Raft Group has been an integral part of a pan-cancer Working Group designed to determine consistent terminology around biomarker or mutational testing. The goal is to communicate to patients and the larger community in plain, patient friendly and consistent language what these terms mean, and how they impact on precision medicine.
Heroes on the Frontline: Dr. Jonathan Trent
The LRG was fortunate to get a few minutes with GIST specialist, Jonathan Trent, MD, Sylvester Comprehensive Cancer Center, who shared his experience with his patients over the past few months during the coronavirus pandemic.
Heroes on the Frontline: Dr. Matthew Lurin
Q&A with a LRG Major Donor & Fundraiser
You Are the Hope
Hope is an important resource during difficulty times. Mary Garland, Director of Communications for the LRG, shares her observations on hope.
Deciphera Announces Health Canada’s Authorization of QINLOCK™ (ripretinib) for the Treatment of 4L Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Health Canada has authorized QINLOCK™ (ripretinib), a switch-control tyrosine kinase inhibitor, for sale in Canada for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib.
Patient of the Month for June: John Garuti Jr.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. John Garuti Jr. shares his story.
Caregiver of the Month for May: Marlene Nei
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Marlene Nei shares her story.